Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene

Br J Dermatol. 2019 Mar;180(3):682-684. doi: 10.1111/bjd.14480. Epub 2018 Dec 6.

Authors

Z Li¹, Q Yang¹, Y Yang², D Wang¹, S Wang¹

Affiliations

¹ Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.
² Department of Medical Genetics, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, China.

PMID: 26875533
DOI: 10.1111/bjd.14480

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Cyclooxygenase 2 Inhibitors / therapeutic use*
Dinoprostone / antagonists & inhibitors
Dinoprostone / metabolism
Etoricoxib / therapeutic use*
Homozygote
Humans
Male
Mutation
Organic Anion Transporters / genetics*
Osteoarthropathy, Primary Hypertrophic / drug therapy*
Osteoarthropathy, Primary Hypertrophic / genetics
Osteoarthropathy, Primary Hypertrophic / pathology
RNA Splice Sites / genetics
Treatment Outcome

Substances

Cyclooxygenase 2 Inhibitors
Organic Anion Transporters
RNA Splice Sites
SLCO2A1 protein, human
Dinoprostone
Etoricoxib